GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
GB Sciences Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 1.994M |
| September 30, 2024 | 1.869M |
| June 30, 2024 | 1.759M |
| March 31, 2024 | 1.759M |
| December 31, 2023 | 1.512M |
| September 30, 2023 | 1.502M |
| June 30, 2023 | 1.436M |
| March 31, 2023 | 1.396M |
| December 31, 2022 | 1.395M |
| September 30, 2022 | 1.390M |
| June 30, 2022 | 1.388M |
| March 31, 2022 | 1.385M |
| December 31, 2021 | 1.842M |
| September 30, 2021 | 4.035M |
| June 30, 2021 | 3.925M |
| March 31, 2021 | 3.887M |
| December 31, 2020 | 4.010M |
| September 30, 2020 | 6.428M |
| June 30, 2020 | 9.993M |
| March 31, 2020 | 5.055M |
| December 31, 2019 | 8.826M |
| September 30, 2019 | 8.801M |
| June 30, 2019 | 11.18M |
| March 31, 2019 | 6.118M |
| December 31, 2018 | 7.733M |
| Date | Value |
|---|---|
| September 30, 2018 | 7.491M |
| June 30, 2018 | 7.634M |
| March 31, 2018 | 7.554M |
| December 31, 2017 | 7.240M |
| September 30, 2017 | 6.714M |
| June 30, 2017 | 3.953M |
| March 31, 2017 | 3.929M |
| December 31, 2016 | 4.842M |
| September 30, 2016 | 6.705M |
| June 30, 2016 | 2.52M |
| March 31, 2016 | 2.612M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.989M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| Arvinas, Inc. | 6.30M |
| Fulcrum Therapeutics, Inc. | 2.76M |
| Definium Therapeutics, Inc. | 36.47M |